Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Affected products
| Vendor | Product | Affected | Fixed |
|---|---|---|---|
| Mirion Medical | EC2 Software NMIS BioDose | < 23.0 | 23.0 |
Advisories 1
- ICSMA-25-336-01 Mirion Medical EC2 Software NMIS BioDose CISA ICS & IT advisories · Dec 2, 2025